(Q33637842)

28 July 2017

1 reference

title

Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders (English)

1 reference

28 July 2017

Sowers W

1

1 reference

28 July 2017

Golden S

series ordinal

2

1 reference

28 July 2017

publication date

1 January 1999

1 reference

Journal of Psychoactive Drugs

28 July 2017

published in

1 reference

28 July 2017

volume

31

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

59-70

1 reference

The course, treatment, and outcome of substance disorder in persons with severe mental illness

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Substance abuse among general psychiatric patients: place of presentation, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Pharmacotherapy of psychiatric syndromes with comorbid chemical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Narcissism: shame, rage and addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Acute dually diagnosed inpatients: the use of self-report symptom severity instruments in persons with depressive disorders and cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Prevalence and patterns of "dual diagnosis" among psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

The epidemiology of the comorbidity of psychiatric and addictive disorders: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Interagency collaboration in services for people with co-occurring mental illness and substance use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Pharmacological treatment of substance-abusing schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Substance abuse and B-cluster disorders. I: Understanding the dual diagnosis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Mental health and substance abuse treatment services for dually diagnosed clients: results of a statewide survey of county administrators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Considerations in using psychotropic medication with dual diagnosis patients in recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Dual diagnosis treatment for patients with schizophrenia who are substance dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Comorbid Anxiety Disorder Among Patients with Substance Abuse Disorders:Risk Factors on Initial Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

Substance Abuse in Patients With Comorbid Anxiety Disorder A Comparative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1999.10471727

10.1080/02791072.1999.10471727

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference